|Day Low/High||19.54 / 21.58|
|52 Wk Low/High||19.39 / 46.64|
A recent trio of acquisition deals indicates the doldrums in the sector may be over.
Omeros Corp. and Eyenovia Inc. were the recipients of positive news this week.
Replimune Group and Akebia Therapeutics provide examples of how to approach stocks in the biotech sector.
Shares of Replimune Group and Eyenovia have swung up and down in 2019 but should be on the rise next year.
T2 Biosystems and Replimune Group have spurted higher in the last couple weeks, with the former doubling in value on encouraging news.